Terms: = Bone cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
3 results:
1. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract] [Full Text] [Related]
2. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract] [Full Text] [Related]
3. NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia.
Zhang H; Zhu L; He H; Zhu S; Zhang W; Liu X; Zhao X; Gao C; Mei M; Bao S; Zheng H
Mol Cancer; 2014 Jan; 13():5. PubMed ID: 24393203
[TBL] [Abstract] [Full Text] [Related]
